Pharmacolog has signed an agreement with Birmingham Children´s Hospital NHS Foundation Trust (BCHNFT) for a technical evaluation of DrugLog to increase patient safety in the treatment of children with intravenous medical drugs.
The agreement with BCHNFT include 2 parts. Firstly, technical and functional tests at the hospital pharmacy och hospital wards, and secondly a research study of DrugLog in a clinical environment in different IV treatments of children.
Pharmacolog’s product DrugLog® raised great interest at the conference GERPAC 5 to 7 October. A total of 550 pharmacists from all over Europe met and discussed different aspects of drug handling and drug compounding.
Pharmacolog was present and exhibited together with its partner for the French-speaking part of Europe, Pharmed SAM. Interest in DrugLog® was great and the two systems that were in place were extensively used for demonstrations.
The purpose of the GERPAC association is to promote the techniques and skills needed for the development of biological and physico-chemical protection in the hospital pharmaceutical environment where toxic drugs are prepared. This year’s me...
Pharmacolog will participate in the 14th European GERPAC congress, 5-7 October, together with our partner Pharmed SAM. The congress takes place in Giens Peninsula France.
The purpose of the GERPAC association is to promote the techniques and skills needed for the development of biological and physico-chemical protection in the hospital pharmaceutical environment where toxic drugs are prepared.
Toxic drug compounding is a focus area for Pharmacolog and the DrugLog system. Therefore, the GERPAC congress is an important opportunity to expose the product to the market. The congress attracts representatives from all the main hospital pharmacies in Europe and key opinion leaders present the late...